Results for tag: "Myelogenous Leukemia Drug"

Myelogenous Leukemia Drugs are a type of medication used to treat myelogenous leukemia, a type of cancer that affects the bone marrow and blood cells. These drugs work by targeting the abnormal cells that cause the disease, and can be used in combination with other treatments such as chemotherapy and radiation. Commonly used drugs include imatinib, dasatinib, nilotinib, and bosutinib. These drugs are used to treat both acute and chronic forms of myelogenous leukemia, and can be used in combination with other treatments to improve outcomes. The Myelogenous Leukemia Drug market is highly competitive, with a number of companies offering a range of products. Major players in the market include Novartis, Pfizer, Bristol-Myers Squibb, and Celgene. Other companies in the market include Amgen, Merck, and Johnson & Johnson. Show Less Read more